NJ State Employees Deferred Compensation Plan - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$16,000
-55.6%
80,0000.0%0.00%
-50.0%
Q3 2018$36,000
-10.0%
80,0000.0%0.01%
-14.3%
Q2 2018$40,000
-78.5%
80,0000.0%0.01%
-78.8%
Q1 2018$186,000
-18.1%
80,0000.0%0.03%
-15.4%
Q4 2017$227,000
-0.9%
80,0000.0%0.04%
-7.1%
Q3 2017$229,000
-7.3%
80,000
-20.0%
0.04%
-10.6%
Q2 2017$247,000
-31.6%
100,0000.0%0.05%
-31.9%
Q1 2017$361,000
+2.0%
100,0000.0%0.07%
-1.4%
Q4 2016$354,000
-12.4%
100,0000.0%0.07%
-16.7%
Q3 2016$404,000
-8.0%
100,0000.0%0.08%
-9.7%
Q2 2016$439,000
-10.2%
100,0000.0%0.09%
-10.6%
Q1 2016$489,000
-68.8%
100,0000.0%0.10%
-67.7%
Q4 2015$1,568,000
+48.8%
100,0000.0%0.32%
+41.2%
Q3 2015$1,054,000
-58.2%
100,0000.0%0.23%
-53.6%
Q2 2015$2,522,000
-9.5%
100,0000.0%0.49%
-8.7%
Q1 2015$2,787,000
+52.7%
100,0000.0%0.54%
+51.1%
Q4 2014$1,825,000
+40.8%
100,0000.0%0.36%
+34.8%
Q3 2014$1,296,000
-20.6%
100,0000.0%0.26%
-18.3%
Q2 2014$1,632,000
-7.6%
100,0000.0%0.32%
-11.0%
Q1 2014$1,767,000100,0000.36%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders